top of page
tokers-guide-find-the-best-weed-in-dc-lo
NEW 1 to 1 photo editing 122024 (17).png
This text notes that Todd Blanche, Trump's nominee for U.S. attorney general, provided written answers regarding his positions on cannabis rescheduling, the 280E tax provision, and enforcement.

Trump’s Pick for Attorney General Keeps His Cards Close on Rescheduling and Recreational Weed

Jul 21, 2026

Source:

Staff

Cannabis Business Times

The federal cannabis landscape is witnessing some major shifts, and keeping tabs on the political heavyweights in Washington is essential for understanding where our favorite plant is headed. Recently, Todd Blanche, the individual selected to lead the Department of Justice as the next U.S. attorney general, submitted formal written responses detailing his perspectives on critical cannabis reforms, specifically addressing the historic shift to Schedule III, the burdensome 280E federal tax rule, and general enforcement strategies.

For everyday cannabis enthusiasts and medical patients, these updates carry significant weight. The transition away from the strict constraints of Schedule I status means that the federal government is finally acknowledging the plant's therapeutic attributes. More importantly, resolving the 280E tax restrictions will allow legal dispensaries and local brands to operate like conventional businesses, opening the door for better price accessibility, higher product quality, and enhanced innovation in the local community. While political figures frequently navigate these legal questions with caution, the fact that cannabis policy remains a front-and-center topic during high-level confirmation processes shows how much mainstream momentum the movement has gained.

As the regulatory framework continues to transform, it is always a smart move for consumers to support compliant local dispensaries and stay informed about regional guidelines. The path toward complete federal normalization might still have a few bureaucratic twists ahead, but seeing top legal officials actively address the commercial and medical realities of the industry is a very encouraging sign for the future of cannabis culture and accessibility.

Recent Reviews

bottom of page